Content about American Society of Clinical Oncology

January 25, 2013

McKesson Specialty Health and the U.S. Oncology Network on Friday announced that Marcus Neubauer accepted the position of medical director of oncology services for McKesson Specialty Health, effective March 1.

THE WOODLANDS, Texas — McKesson Specialty Health and the U.S. Oncology Network on Friday announced that Marcus Neubauer accepted the position of medical director of oncology services for McKesson Specialty Health, effective March 1. 

May 24, 2012

Two drug makers are looking to win approval for an experimental drug in patients with colorectal cancer that has spread to other parts of the body.

SOUTH SAN FRANCISCO, Calif. — Two drug makers are looking to win approval for an experimental drug in patients with colorectal cancer that has spread to other parts of the body.

Onyx Pharmaceuticals announced that Bayer HealthCare had submitted a regulatory approval application to the Food and Drug Administration for regorafenib in patients with metastatic colorectal cancer.

May 16, 2011

Drug maker Eli Lilly will present data from more than 30 studies at the American Society of Clinical Oncology’s annual meeting in Chicago next month, the company said Monday.

INDIANAPOLIS — Drug maker Eli Lilly will present data from more than 30 studies at the American Society of Clinical Oncology’s annual meeting in Chicago next month, the company said Monday.

Studies will include “PARAMOUNT,” a late-stage clinical trial investigating the drug Alimta (pemetrexed) in patients with advanced non-squamous non-small cell lung cancer, as well as studies on Gemzar (gemcitabine) and Erbitux (cetuximab) with partner companies Bristol-Myers Squibb and Merck KGaA.

June 15, 2010

Drug maker OXiGENE has finished enrolling patients for a mid-stage clinical trial of a lung...